Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12.7M
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
2.61M
-
Shares change
-
+392K
-
Total reported value, excl. options
-
$44.3M
-
Value change
-
+$5.72M
-
Number of buys
-
40
-
Number of sells
-
-24
-
Price
-
$16.99
Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q3 2016
71 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q3 2016.
IRADIMED CORP - Common Stock (IRMD) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.61M shares
of 12.7M outstanding shares and own 20.46% of the company stock.
Largest 10 shareholders include Conestoga Capital Advisors, LLC (573K shares), VANGUARD GROUP INC (231K shares), JFS WEALTH ADVISORS, LLC (190K shares), Mondrian Investment Partners LTD (136K shares), BlackRock Fund Advisors (112K shares), Grandeur Peak Global Advisors, LLC (107K shares), WASATCH ADVISORS INC (97K shares), MCKINLEY CAPITAL MANAGEMENT LLC /DELAWARE (89.6K shares), Spark Investment Management LLC (71K shares), and AMERIPRISE FINANCIAL INC (65.2K shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.